• Go to navigation
  • Go to content
AstraZeneca Ireland

You are here

  • May 21, 2013

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • Products
  • Investors
  • Healthcare professionals
  • Patients
  • Careers
  • Find us
  • Patient Group Support
  • Site map

"Our vision is to be a global biopharmaceutical business delivering great medicines to patients through innovative science and excellence in development and commercialisation."

 

 AstraZeneca is ranked as one of the world’s leading pharmaceutical companies.  In Ireland, AstraZeneca Pharmaceuticals (Ireland) Ltd. is primarily a Sales and Marketing Company, centred in College Park House, 20 Nassau Street, Dublin 2.

At AstraZeneca Ireland, we aim to stimulate continued creativity throughout our organisation by maintaining a culture in which our people feel valued, energised and rewarded for their ideas and contribution to our success - ideas which can make a difference in all aspects of our business and to healthcare in Ireland.

Currently about 60  people are employed by AstraZeneca in Ireland with a wide range of expertise in different areas including sales, marketing, medical & regulatory affairs, IT, finance and administration. Our Dublin office serves as a hub of communication between our office-based staff and more than half the company's employees that are directly involved in promotion of the company's medicines to healthcare professionals throughout the country.

We market medicines that are designed to improve the health and quality of life of patients in Ireland - medicines which are innovative and effective. In Ireland, AstraZeneca's main focus is in 5 therapy areas: Cardiovascular disease, Diabetes medicines with our Alliance Partners BMS, Pain, Neuroscience/CNS, Oncology and Respiratory.

Worldwide, AstraZeneca invested over €4 billion in R & D in 2012  on research and development highlighting our dedication to finding new medicines that make a real difference to patients’ lives.

  • Latest news

    For the latest press releases from AstraZeneca please visit AstraZeneca's International site.

    Health related news can be found at  Patient Health International.

  • Advanced search

Page tools

  • Print
  • Bookmark this page

Share price

London
-0.36 33.55 GBP
Stockholm
-0.04 338.90 SEK
New York
-0.00 51.50 USD

At May 21, 2013 11:23 AM CEST

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013